Cargando…
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration
All-trans-retinoic acid (ATRA) is the standard of care for the management of acute promyelocytic leukemia (APL), but can be associated with differentiation syndrome (DS). Over a seven-year period, we sought to determine the impact of ATRA initiation time on the development of DS. ATRA administration...
Autores principales: | Nauffal, Mary, Werner, Lillian, Ni, Jian, Stone, Richard M., DeAngelo, Daniel J., McDonnell, Anne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904816/ https://www.ncbi.nlm.nih.gov/pubmed/31867205 http://dx.doi.org/10.1016/j.lrr.2019.100189 |
Ejemplares similares
-
Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells
por: Niu, Chao Shi, et al.
Publicado: (2010) -
Functional characterization of all‐trans retinoic acid‐induced differentiation factor (ATRAID)
por: Mehrasa, Roya, et al.
Publicado: (2023) -
Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid
por: Silvis, Anne M., et al.
Publicado: (2015) -
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
por: Bahlool, Ahmad Z., et al.
Publicado: (2022) -
All-trans retinoic acid suppresses exocrine differentiation and branching morphogenesis in the embryonic pancreas
por: Shen, Chia-Ning, et al.
Publicado: (2007)